US Stock MarketDetailed Quotes

Avita Medical (RCEL)

Watchlist
  • 4.990
  • -0.170-3.29%
Close Apr 16 15:59 ET
  • 4.990
  • 0.0000.00%
Post 20:01 ET
152.85MMarket Cap-2.87P/E (TTM)

Avita Medical (RCEL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
11.45%71.61M
-4.30%17.62M
-12.71%17.06M
21.21%18.42M
66.73%18.51M
28.14%64.25M
29.67%18.41M
43.25%19.55M
29.29%15.2M
5.25%11.1M
Operating revenue
11.45%71.61M
-4.30%17.62M
-12.71%17.06M
21.21%18.42M
66.73%18.51M
28.14%64.25M
29.67%18.41M
43.25%19.55M
29.29%15.2M
5.25%11.1M
Cost of revenue
40.69%12.79M
44.91%3.3M
-0.09%3.19M
64.33%3.47M
87.24%2.83M
16.89%9.09M
26.95%2.28M
50.97%3.19M
-4.22%2.11M
-9.24%1.51M
Gross profit
6.63%58.82M
-11.26%14.31M
-15.17%13.88M
14.25%14.95M
63.50%15.68M
30.20%55.16M
30.06%16.13M
41.83%16.36M
37.02%13.08M
7.97%9.59M
Operating expense
-9.31%101.35M
-5.23%24.72M
-23.65%23.03M
-9.10%26.1M
2.65%27.51M
31.44%111.75M
5.72%26.08M
44.75%30.16M
38.59%28.71M
42.58%26.8M
Selling and administrative expenses
-11.90%80.51M
-10.38%19.03M
-22.05%19.28M
-11.93%20.98M
-1.75%21.22M
39.26%91.39M
18.18%21.23M
48.50%24.73M
47.33%23.82M
45.62%21.6M
-Selling and marketing expense
-8.69%53.14M
-15.39%11.94M
-20.41%12.05M
-12.19%14.31M
17.36%14.83M
56.06%58.2M
38.11%14.11M
43.79%15.14M
62.97%16.3M
93.27%12.64M
-General and administrative expense
-17.54%27.37M
-0.48%7.09M
-24.64%7.23M
-11.34%6.67M
-28.71%6.39M
17.16%33.2M
-8.08%7.12M
56.60%9.59M
21.96%7.52M
8.05%8.96M
Research and development costs
2.35%20.84M
17.34%5.69M
-30.95%3.75M
4.71%5.12M
20.99%6.28M
-2.21%20.36M
-28.31%4.85M
23.53%5.43M
-3.72%4.89M
13.26%5.19M
Operating profit
24.84%-42.53M
-4.53%-10.41M
33.70%-9.15M
28.65%-11.15M
31.26%-11.83M
-32.68%-56.59M
18.87%-9.96M
-48.36%-13.81M
-39.94%-15.62M
-73.61%-17.21M
Net non-operating interest income expense
6.66%-5M
3.70%-1.25M
6.70%-1.27M
7.05%-1.25M
9.07%-1.23M
-369.03%-5.36M
-15.69%-1.3M
-13,490.00%-1.36M
-19,142.86%-1.35M
-33,800.00%-1.36M
Non-operating interest expense
-6.66%5M
-3.70%1.25M
-6.70%1.27M
-7.05%1.25M
-9.07%1.23M
369.03%5.36M
15.69%1.3M
13,490.00%1.36M
19,142.86%1.35M
33,800.00%1.36M
Other net income (expense)
-736.81%-1.04M
106.35%20K
-157.58%-2.75M
54.19%2.48M
-1,098.48%-791K
-98.08%163K
-104.97%-315K
-273.66%-1.07M
101.12%1.61M
-109.10%-66K
Other non- operating income (expenses)
-736.81%-1.04M
106.35%20K
-157.58%-2.75M
54.19%2.48M
-1,098.48%-791K
-98.08%163K
-104.97%-315K
-273.66%-1.07M
101.12%1.61M
-109.10%-66K
Income before tax
21.39%-48.58M
-0.59%-11.64M
18.86%-13.17M
35.44%-9.92M
25.64%-13.85M
-74.97%-61.79M
-64.04%-11.57M
-86.56%-16.23M
-48.11%-15.36M
-102.70%-18.63M
Income tax
-79.63%11K
-189.47%-17K
153.57%15K
-87.88%4K
-73.33%8K
-18.18%54K
58.33%19K
-354.55%-28K
153.85%33K
0.00%30K
Net income
21.44%-48.59M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-74.80%-61.85M
-64.03%-11.59M
-86.01%-16.21M
-48.24%-15.39M
-102.36%-18.66M
Net income continuous Operations
21.44%-48.59M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-74.80%-61.85M
-64.03%-11.59M
-86.01%-16.21M
-48.24%-15.39M
-102.36%-18.66M
Minority interest income
Net income attributable to the parent company
21.44%-48.59M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-74.80%-61.85M
-64.03%-11.59M
-86.01%-16.21M
-48.24%-15.39M
-102.36%-18.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.44%-48.59M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-74.80%-61.85M
-64.03%-11.59M
-86.01%-16.21M
-48.24%-15.39M
-102.36%-18.66M
Basic earnings per share
27.20%-1.74
13.64%-0.38
25.81%-0.46
36.67%-0.38
27.40%-0.53
-70.71%-2.39
-57.14%-0.44
-82.35%-0.62
-46.34%-0.6
-97.30%-0.73
Diluted earnings per share
27.20%-1.74
13.64%-0.38
25.81%-0.46
36.67%-0.38
27.40%-0.53
-70.71%-2.39
-57.14%-0.44
-82.35%-0.62
-46.34%-0.6
-97.30%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 11.45%71.61M-4.30%17.62M-12.71%17.06M21.21%18.42M66.73%18.51M28.14%64.25M29.67%18.41M43.25%19.55M29.29%15.2M5.25%11.1M
Operating revenue 11.45%71.61M-4.30%17.62M-12.71%17.06M21.21%18.42M66.73%18.51M28.14%64.25M29.67%18.41M43.25%19.55M29.29%15.2M5.25%11.1M
Cost of revenue 40.69%12.79M44.91%3.3M-0.09%3.19M64.33%3.47M87.24%2.83M16.89%9.09M26.95%2.28M50.97%3.19M-4.22%2.11M-9.24%1.51M
Gross profit 6.63%58.82M-11.26%14.31M-15.17%13.88M14.25%14.95M63.50%15.68M30.20%55.16M30.06%16.13M41.83%16.36M37.02%13.08M7.97%9.59M
Operating expense -9.31%101.35M-5.23%24.72M-23.65%23.03M-9.10%26.1M2.65%27.51M31.44%111.75M5.72%26.08M44.75%30.16M38.59%28.71M42.58%26.8M
Selling and administrative expenses -11.90%80.51M-10.38%19.03M-22.05%19.28M-11.93%20.98M-1.75%21.22M39.26%91.39M18.18%21.23M48.50%24.73M47.33%23.82M45.62%21.6M
-Selling and marketing expense -8.69%53.14M-15.39%11.94M-20.41%12.05M-12.19%14.31M17.36%14.83M56.06%58.2M38.11%14.11M43.79%15.14M62.97%16.3M93.27%12.64M
-General and administrative expense -17.54%27.37M-0.48%7.09M-24.64%7.23M-11.34%6.67M-28.71%6.39M17.16%33.2M-8.08%7.12M56.60%9.59M21.96%7.52M8.05%8.96M
Research and development costs 2.35%20.84M17.34%5.69M-30.95%3.75M4.71%5.12M20.99%6.28M-2.21%20.36M-28.31%4.85M23.53%5.43M-3.72%4.89M13.26%5.19M
Operating profit 24.84%-42.53M-4.53%-10.41M33.70%-9.15M28.65%-11.15M31.26%-11.83M-32.68%-56.59M18.87%-9.96M-48.36%-13.81M-39.94%-15.62M-73.61%-17.21M
Net non-operating interest income expense 6.66%-5M3.70%-1.25M6.70%-1.27M7.05%-1.25M9.07%-1.23M-369.03%-5.36M-15.69%-1.3M-13,490.00%-1.36M-19,142.86%-1.35M-33,800.00%-1.36M
Non-operating interest expense -6.66%5M-3.70%1.25M-6.70%1.27M-7.05%1.25M-9.07%1.23M369.03%5.36M15.69%1.3M13,490.00%1.36M19,142.86%1.35M33,800.00%1.36M
Other net income (expense) -736.81%-1.04M106.35%20K-157.58%-2.75M54.19%2.48M-1,098.48%-791K-98.08%163K-104.97%-315K-273.66%-1.07M101.12%1.61M-109.10%-66K
Other non- operating income (expenses) -736.81%-1.04M106.35%20K-157.58%-2.75M54.19%2.48M-1,098.48%-791K-98.08%163K-104.97%-315K-273.66%-1.07M101.12%1.61M-109.10%-66K
Income before tax 21.39%-48.58M-0.59%-11.64M18.86%-13.17M35.44%-9.92M25.64%-13.85M-74.97%-61.79M-64.04%-11.57M-86.56%-16.23M-48.11%-15.36M-102.70%-18.63M
Income tax -79.63%11K-189.47%-17K153.57%15K-87.88%4K-73.33%8K-18.18%54K58.33%19K-354.55%-28K153.85%33K0.00%30K
Net income 21.44%-48.59M-0.28%-11.62M18.62%-13.19M35.56%-9.92M25.72%-13.86M-74.80%-61.85M-64.03%-11.59M-86.01%-16.21M-48.24%-15.39M-102.36%-18.66M
Net income continuous Operations 21.44%-48.59M-0.28%-11.62M18.62%-13.19M35.56%-9.92M25.72%-13.86M-74.80%-61.85M-64.03%-11.59M-86.01%-16.21M-48.24%-15.39M-102.36%-18.66M
Minority interest income
Net income attributable to the parent company 21.44%-48.59M-0.28%-11.62M18.62%-13.19M35.56%-9.92M25.72%-13.86M-74.80%-61.85M-64.03%-11.59M-86.01%-16.21M-48.24%-15.39M-102.36%-18.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.44%-48.59M-0.28%-11.62M18.62%-13.19M35.56%-9.92M25.72%-13.86M-74.80%-61.85M-64.03%-11.59M-86.01%-16.21M-48.24%-15.39M-102.36%-18.66M
Basic earnings per share 27.20%-1.7413.64%-0.3825.81%-0.4636.67%-0.3827.40%-0.53-70.71%-2.39-57.14%-0.44-82.35%-0.62-46.34%-0.6-97.30%-0.73
Diluted earnings per share 27.20%-1.7413.64%-0.3825.81%-0.4636.67%-0.3827.40%-0.53-70.71%-2.39-57.14%-0.44-82.35%-0.62-46.34%-0.6-97.30%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More